Minister @patmcfaddenmp & Lord Vallance visited @GSTTnhs to see UK tech enabling rapid bedside diagnosis of respiratory infections.
The project with @OxfordNanopore is being rolled out to up to 30 NHS Trusts.
@LongDesertTrain The main thing we need is an nsp5 inhibitor that has limited drug-drug interactions (ie is not dependent on CYP3A4 metabolism). Interested in ibuzatrelavir’s progress.
@DevanSinha Hard disagree. ‘If this offer is accepted… we will remain on average 20.8% behind’ -BMA. Who accepts the first offer? The real trade unions are laughing.
For this week's #MicrobeMonday, we wanted to share this fascinating podcast from @Letstalkmicro1 🦠 🎙️
Listen now to hear @LaraPayne85, @lukebsnell and @madelaam discuss how the novel species Variovorax durovernensis was discovered and the story behind its name ⬇️
💦@lukebsnell & team use nanopore metagenomics & other measures to assess the microbiome, resistome & effects of decontamination in hospital sinks
💧Metagenomics can measure the composition of the drainome & assess decontamination interventions
https://t.co/TsJrGXTWyW
Same day @nanopore respiratory metagenomics for pneumonia; bacteria, fungi and viruses in one tube. We are approaching the holy grail of infectious diseases diagnostics https://t.co/uFWUwqcQ65
'The drainome' - just published by @jhieditor: using @nanopore metagenomics and other measures to assess the microbiome, resistome and effects of decontamination in hospital sinks. https://t.co/ylg9Gkq3b4 @simon999@madelaam@jonotter@jonathanCIDR
we need to make sure our decontamination interventions are effective - this decontamination did not change microbial counts and led to expansion of Pseudomonas - what's the point?
Congrats to @lukebsnell@madelaam for your oral presentation at #ECCMID2024#ESCMIDGlobal 👏🏼
🧬| The drainome: metagenomics of sink wastewater on hospital wards can monitor antimicrobial resistance and identify reservoirs of carbapenamase-producing organisms |🚰
Multicenter case series data in patients with persistent SARS-CoV-2 infection (median 103 days) in the setting of CD20 depleting therapy. Most received prolong Paxlovid (median 10 days, as long as 18 days) plus sotrovimab or IVIG. Lesser # got remdesivir. https://t.co/hgl3rQlIBW
Great to see this case series published. Difficult to treat - persistent #COVID19 infection. Great collaboration across UK and Ireland - the All #Ireland Infectious Diseases Cohort @CEPHR_UCD@RCSI_Irl@ucddublin